Liquid biopsies are minimally invasive tests that detect cancer-related information from a blood sample. They analyze circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), and other biomarkers. This method is particularly useful for monitoring cancer progression and response to treatment, offering a less invasive alternative to traditional tissue biopsies.
